Prophylaxis Roles of IL-2 Treatment on GVHD After Transplantation
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The effects of haploidentical rhG-CSF-mobilized unmanipulated blood and marrow
transplantation (HBMT) on hematological malignancies are well established.The aim of this
prospective cohort trial is to determine if acute graft-versus-host disease (aGVHD) could be
decreased with IL2 therapy post HBMT.